Only dual route gene transfer therapy in development ... it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for SGT-212, the Company’s, AAV-based gene ...
Only dual route gene transfer therapy in development to treat Friedreich’s ataxia with FDA IND clearance and Fast Track designation ...
Administer medications via the oral route when possible ... tube feeding for at least one to two hours before and after medication administration if drug absorption may be affected.
U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...
A court-authorized search warrant was obtained for their home, where investigators recovered a significant amount of illicit drugs. The items seized during the search included 41.7 grams of ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to severe acute pain.
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback